gut.bmj1d
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
The treatment of IBD has evolved significantly over the past 15 years. Historically, steroids and immunosuppressive drugs, such as methotrexate (MTX), azathioprine (AZA) and 6-mercaptopurine (6-MP) ...
gut.bmj1d
Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Correspondence to Dr Mayur Garg, Eastern Health Clinical School, Monash University, Box Hill, VIC 3800, Australia; mayur.garg{at}monash.edu Objective We evaluated the influence of the ...
gut.bmj1d
Fibrosis in IBD: from pathogenesis to therapeutic targets
Background Intestinal fibrosis resulting in stricture formation and obstruction in Crohn’s disease (CD) and increased wall stiffness leading to symptoms in ulcerative colitis (UC) is among the largest ...
gut.bmj1d
Enterohepatic circulation of bile acids after cholecystectomy.
Bile acid metabolism was investigated in 10 patients after cholecystectomy, 10 gallstone patients, and 10 control subjects. Diurnal variations of serum levels of cholic and chenodeoxycholic acid ...
gut.bmj1d
Colon cancer stem cells
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj2d
Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS
Correspondence to Dr Madhusudan Grover, Enteric NeuroScience Program, Division of Gastroenterology & Hepatology, Mayo Clinic, 200 First Street SW, Rochester MN 55905, USA; ...
gut.bmj2d
Alterations in intestinal permeability
The goal of this review is to describe barrier function of the intestine, the structure of the tight junction, methods to evaluate intestinal permeability, and most importantly the relevance of ...
gut.bmj2d
Gastritis due to spiral shaped bacteria other than Helicobacter pylori: clinical, histological, and ultrastructural findings.
An intensive histological search for Helicobacter pylori in gastric biopsy specimens has led to the detection of other spiral shaped bacteria in the human gastric mucosa. The clinical and ...
gut.bmj2d
Design of treatment trials for functional gastrointestinal disorders
Until recently many clinical trials of functional gastrointestinal disorders (FGIDs) suffered from important weaknesses in trial design, study execution, and data analysis. This makes it difficult to ...
gut.bmj2d
Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.
Department of Gastrointestinal Oncology, Centre for Adult Diseases, Osaka, Japan. The effect on the recurrence of gastric ulcers after suppression of Helicobacter pylori by combined treatment with ...
gut.bmj3d
Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice
Correspondence to Professor Lee-Yan Sheen, Institute of Food Science and Technology, National Taiwan University, Taipei 106, Taiwan; lysheen{at}ntu.edu.tw and Professor Ming-Shiang Wu, Department of ...
gut.bmj3d
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial
Correspondence to Professor Lu Qi, Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70112, USA; lqi1{at}tulane.edu Objective Alterations in ...